ENTITY
Brii Biosciences

Brii Biosciences (2137 HK)

36
Analysis
Health Care • China
Brii Biosciences is a biotechnology company focused on developing therapies for infectious and central nervous system diseases. The company has a broad pipeline of therapeutic candidates, with lead programs targeting hepatitis B virus (HBV) infection, and also develops treatments for multi-drug resistant bacterial infections. Brii Biosciences is headquartered in Beijing, China, and was founded in 2017.
more
Company Event • 19 Mar 2027 20:30 • Upcoming
Add To Calendar

H2 2026

Company Event • 21 Aug 2026 08:30 • Latest

H1 2026

Company Event • 20 Mar 2026 20:30

H2 2025

Company Event • 19 Sep 2025 16:00 • Upcoming
Add To Calendar

Corporate presentation

Company Event • 21 Aug 2025 21:00

H1 2025

x